News

TRIAL UPDATE: First patient enrolled EORTC TOLERANCE July 28, 2022 TRIAL UPDATE: First patient was enrolled in the EORTC TOLERANCE academic clinical trial in elderly patients with advanced soft tissue sarcoma. TOLERANCE is an international study with 9 participating countries. We are proud to support our partner EORTC and would like to say thank you for the good collaboration. You can […]

New Funding Opportunity: Patient-Centric Clinical Trial Team Science Awards July 19, 2022 The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards

Lithuania liberalizes labor migration July 14, 2022 We are excited to celebrate liberalization of labor migration of non-EU nationals passed into law in late June by the Lithuanian parliament. This takes place just under a year after the team at Lithuanian Free Market Institute (LFMI) initiated discussions on systemic reform to address looming demographic and labor market

Scientists discover genes that affect the risk of developing pre-leukaemia July 14, 2022 The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today in Nature Genetics. The finding, made in

Going the extra mile for people with pancreatic cancer July 12, 2022 BRUSSELS – The Anticancer Fund is partnering with the Rising Tide Foundation for Clinical Cancer Research to support a trial testing a novel strategy in the treatment of patients with pancreatic cancer. As people with pancreatic cancer are currently lacking treatment options, the